FIELD: biotechnology.
SUBSTANCE: described is a composition for eliciting an immune response in an animal against FMDV, comprising an effective amount of a recombinant viral vector expressing antigen of foot-and-mouth disease virus (FMDV), wherein the FMDV antigen comprises a polypeptide having the sequence presented in SEQ ID NO: 2, 4, 6 or 8, and a pharmaceutically or veterinarily acceptable carrier, excipient, adjuvant, or excipient embraces vaccines or anti-FMDV compositions. What is also described is a method for vaccination with said composition.
EFFECT: invention can be used for protection of animals, in particular sheep, cows, goats or pigs, from FMDV.
12 cl, 6 tbl, 8 ex, 15 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| FMDV RECOMBINANT VACCINES AND USE THEREOF | 2015 |
|
RU2745373C2 |
| FMDV-E2 FUSION PROTEINS AND USE THEREOF | 2016 |
|
RU2714428C2 |
| REASSORTANT BTV AND AHSV VACCINES | 2013 |
|
RU2656187C2 |
| RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
| RECOMBINANT VACCINE AGAINST AVIAN FLU AND APPLICATION THEREOF | 2009 |
|
RU2559527C2 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
| METHOD OF PRODUCING RECOMBINANT VIRAL VECTOR APMV-8 | 2010 |
|
RU2592544C2 |
| RECOMBINANT VACCINES AGAINST BLUETONGUE VIRUS, THEIR USE | 2011 |
|
RU2575599C2 |
| RECOMBINANT HVT-VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND VACCINES CONTAINING THESE VECTORS | 2017 |
|
RU2752836C2 |
